Literature DB >> 10636022

[Lactic acidosis and multi-organ failure secondary to anti-retroviral therapy in HIV-infected patients].

B Mégarbane1, F Brivet, J M Guérin, F J Baud.   

Abstract

A SERIOUS COMPLICATION: Antiretroviral therapy may induce severe lactic acidosis with multiorgan failure in HIV-infected patients. CLINICAL DESCRIPTION: Patients are admitted for onset of dyspnea, abdominal pain, nausea, vomiting or diarrhea, with weight loss and general fatigue over the past few days. Physical findings are usually not contributive except for constant presence of hepatomegaly. Laboratory examinations reveal severe metabolic acidosis with increased anion gap and serum lactate elevation. Perturbations of hepatic and pancreatic enzyme values may exist. Echotomography and CT scan demonstrate fatty liver, confirmed by histological examination of the biopsy. Outcome in the intensive care unit is generally multiorgan failure and death. Symptomatic treatments, mechanical ventilation, bicarbonate infusion or hemodialysis appear to be ineffective in most severe cases. PATHOPHYSIOLOGY: Antiretroviral nuceloside analogs are inhibitors of mitochondrial DNA polymerase gamma. This explains the dysfunction of the mitochondrial respiratory chain, leading to inhibition of lactate metabolism in the liver and enhancement of serum lactate and acetone body levels. Elevation of lactate/pyruvate and beta-hydroxybutyrate/acetoacetate ratios suggest mitochondrial dysfunction. Many other co-factors may be associated. THERAPEUTIC APPROACH: Several therapeutic strategies (thiamine, coenzyme <Aucun> Q, carnitine and riboflavin) have been tried. They rely on the pathophysiological hypothesis that sustained cellular dysfunctions cause this clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10636022

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

2.  HAART toxicity masquerading as a surgical abdomen.

Authors:  Anthony Feghali; Yi Wang; Evelyn Irizarry; Meno Lueders
Journal:  Int J Surg Case Rep       Date:  2015-12-03

3.  Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill.

Authors:  Houman Khosravani; Reza Shahpori; H Thomas Stelfox; Andrew W Kirkpatrick; Kevin B Laupland
Journal:  Crit Care       Date:  2009-06-12       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.